LIFT BioSciences
Biotechnology ResearchEngland, United Kingdom11-50 Employees
LIFT BioSciences is a biotechnology research company based in London, United Kingdom, at 2 Royal College Street. The company is pursuing a novel allogeneic immunotherapy platform based on Immuno-Modulatory Alpha Neutrophils (IMANs) for solid tumors. The technology leverages neutrophils' innate tumor-homing and infiltrating abilities, their capacity to kill cancer cells directly, and to coordinate broader immune responses. The company has 11-50 employees and has undergone leadership changes, including the appointment of a Chief Executive Officer in 2026 and a Chief Scientific Officer in 2025. Recent activity includes a collaboration with the University of Galway to advance a clinical trial in Ireland and a Series A financing completed in 2024.